LMAT - LeMaitre Vascular - Stock Price & Dividends
Exchange: USA Stocks • Country: United States • Currency: USD • Type: Common Stock • ISIN: US5255582018
Vascular Grafts, Catheters, Patches, Shunts, Biosynthetic Grafts, Medical Tapes
LeMaitre Vascular, Inc. is a leading developer, manufacturer, and marketer of medical devices and implants used in vascular surgery worldwide. The company's product portfolio includes a range of innovative solutions designed to improve patient outcomes and enhance surgical procedures.
One of the company's key offerings is its human cadaver tissue cryopreservation services, which provide surgeons with access to high-quality tissue for use in various vascular procedures. Additionally, LeMaitre Vascular offers a range of catheters, including angioscopes, embolectomy catheters, thrombectomy catheters, occlusion catheters, and perfusion catheters, which are used to visualize, remove blood clots, and restore blood flow in arteries and veins.
The company's biologic grafts and patches are also an essential part of its product lineup. These include the artegraft biologic graft, a bovine carotid artery used for dialysis access, as well as XenoSure, VascuCel, and CardioCel biologic patches, which are used for vessel repair, heart repair and reconstruction, and neonatal repairs. LeMaitre Vascular's cardiovascular patches and carotid shunts are also designed to facilitate complex vascular procedures.
In addition to these products, the company offers a range of innovative solutions, including biosynthetic vascular grafts, vascular grafts, and radiopaque tape, which enables surgeons to locate tributaries or lesions beneath the skin. Valvulotomes, which are used to cut or disrupt valves in the saphenous vein, and closure systems, which attach vessels to one another with titanium clips, are also part of the company's product portfolio.
LeMaitre Vascular markets its products through a direct sales force and distributors, providing surgeons and healthcare professionals with access to its innovative solutions. With a strong commitment to innovation and customer satisfaction, the company has established itself as a leader in the vascular surgery market.
Headquartered in Burlington, Massachusetts, LeMaitre Vascular, Inc. was founded in 1983 and has a rich history of innovation and growth. The company's website, https://www.lemaitre.com, provides further information on its products, services, and mission to improve patient outcomes in vascular surgery.
Drawdown (Underwater) Chart
LMAT Stock Overview
Market Cap in USD | 1,979m |
Sector | Healthcare |
Industry | Medical Instruments & Supplies |
GiC SubIndustry | Health Care Equipment |
TER | 0.00% |
IPO / Inception | 2006-10-19 |
LMAT Stock Ratings
Growth 5y | 81.5 |
Fundamental | 77.7 |
Dividend | 55.0 |
Rel. Performance vs Sector | 4.45 |
Analysts | 4.22/5 |
Fair Price Momentum | 110.16 USD |
Fair Price DCF | 35.18 USD |
LMAT Dividends
Dividend Yield 12m | 0.68% |
Yield on Cost 5y | 1.83% |
Dividends CAGR 5y | 10.49% |
Payout Consistency | 100.0% |
LMAT Growth Ratios
Growth 12m | 87.94% |
Growth Correlation 12m | 98% |
Growth Correlation 3m | 71.1% |
CAGR 5y | 21.48% |
CAGR/Mean DD 5y | 1.40 |
Sharpe Ratio 12m | 2.47 |
Alpha vs SP500 12m | 51.95 |
Beta vs SP500 5y weekly | 0.93 |
ValueRay RSI | 31.20 |
Volatility GJR Garch 1y | 34.72% |
Price / SMA 50 | 1.22% |
Price / SMA 200 | 19.41% |
Current Volume | 60.5k |
Average Volume 20d | 105.4k |
External Links for LMAT Stock
Wall Street Journal • Benzinga • Yahoo Finance
Tweets
X • Stocktwits
Fund Manager Positions
Dataroma • Stockcircle
As of October 18, 2024, the stock is trading at USD 89.69 with a total of 60,467 shares traded.
Over the past week, the price has changed by +0.46%, over one month by +0.98%, over three months by +3.91% and over the past year by +83.82%.
According to ValueRays Forecast Model, LMAT LeMaitre Vascular will be worth about 122 in October 2025. The stock is currently trading at 89.69. This means that the stock has a potential upside of +35.99%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 95.8 | 6.76 |
Analysts Target Price | 67.9 | -24.3 |
ValueRay Target Price | 122 | 36.0 |